Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: BP To Shutter Oil Refinery In Brisbane, Australia

Wed, 02nd Apr 2014 10:27

LONDON (Alliance News) - The following is a summary of top news stories Wednesday.
----------
COMPANIES
----------

BP PLC announced it intends to halt refinery operations at its major Bulwer Island refinery in Brisbane, Australia by mid-2015, as the Australian operations of major commodities players continue to struggle. The oil and gas major said the growth of very large refineries in the Asia-Pacific region was driving structural change within the fuels supply chain in Australia and putting significant pressure on smaller scale plants.

----------
Anglo-Australian mining giant BHP Billiton said the company expects global growth in demand for both energy and metallurgical coal over the coming decades, with productivity key to generating acceptable returns. While discussing the global outlook for coal at CEDA's Energy and Resources series in Brisbane, President of BHP Billiton's global Coal business, Dean Dalla Valle, outlined the importance of productivity and a high-performing culture to ensure a long-term sustainable coal export industry in Australia.

---------

Tullow Oil PLC said it intends to offer USD500 million worth of senior notes that will be due in 2022 to raise funds to repay certain other existing debts. In a statement, the company said the interest rate, offer price and other terms on the notes will be determined when the offer is priced, but interest will be paid semi-annually and the notes will be guaranteed by some of its subsidiaries.
----------
G4S PLC said it has won a seven-year deal with Netherlands Railways to provide cash services like transporting cash to ticket offices and managing ticket machines. It didn't give any financial details apart from saying it was a multi-million pound deal. In a statement, G4S said that it will provide services to all 400 stations across the country’s rail network from August 1. It will transport cash to all manned and unmanned ticket offices, manage all ticket machines, and provide machine maintenance services.
----------
Online fashion retailer ASOS PLC reported a drop in profits for the first half of the year, as it invested in doubling its sales capacity. However, sales growth remained strong at the popular online clothing and accessories retailer, with retail sales in the first half rising by 34%. ASOS is pumping a large amount of money into its infrastructure, especially into IT and warehousing, which Chief Executive Officer Nick Robertson says is costly but necessary for future growth.
----------
Bus and rail company FirstGroup PLC said that its operating profit in its last financial year was in line with expectations, excluding a GBP14 million hit on its First Student and Greyhound bus operations from the severe winter weather in the US. In a trading update, the company said US dollar revenue is expected to be down 1.8% on the year at First Student and down 2.9% at Greyhound due to the severe winter weather that regularly swept across the US between December and March.
----------
GlaxoSmithKline PLC said it had chosen to stop the Phase III trial of its MAGE-A3 cancer immunotherapeutic in non-small cell lung cancer patients, as it said it would not be possible to identify a sub-population of MAGE-A3 positive patients with a specific gene signature that might benefit from the treatment. The trial of the immunotherapeutic missed its first and second co-primary endpoints, Glaxo said on March 20, as it did not significantly extend disease free survival compared to a placebo in either MAGE-A3 positive patients, or MAGE-A3 patients who did not receive chemotherapy.
----------
British retailer Marks and Spencer Group PLC is planning to open 250 new stores outside the UK over the next three years, as part of its global expansion plans. M&S, which held an investor day in Paris on Tuesday, said 60% of the new stores will be franchised. It said that it will be entering new territories with existing partners, and expects the global expansion to increase revenues by 25% and profits by 40% over the next three years.
----------
MARKETS
----------
UK stock indices are making small gains after data revealed the UK construction sector continues to boom.
----------
FTSE 100: up 0.2% at 6669.6
FTSE 250: up 0.2% at 16445.74
AIM ALL-SHARE: up 0.2% at 850.57
----------
The euro is flat against the dollar after Eurozone producer prices declined unexpectedly in February in its fastest fall since December 2009, raising fears of deflation.
----------
GBP-USD: up at USD1.6640
EUR-USD: flat at USD1.3792

GOLD: up at USD1283.55 per ounce
OIL (Brent): up at USD105.41 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
UK house prices increased at the fastest pace since May 2010, data from Nationwide Building Society showed. House prices advanced 9.5% in March from last year, following a 9.4% rise in February. The increase was less than the 9.7% growth forecast by economists and was the biggest since May 2010, when prices rose 9.8%. A typical house now cost GBP180,264, the highest level since January 2008. On a monthly basis, house prices gained only 0.4% in March, which was slower than the 0.7% increase posted in February and 0.8% rise forecast by economists. Nonetheless, this was the fifteenth consecutive rise in prices.
----------
The UK construction sector expanded for the eleventh month in a row in March, survey data from Markit Economics showed. The Markit/Chartered Institute of Purchasing & Supply Purchasing Managers' Index fell marginally to 62.5 from 62.6 in February. The score was forecast to rise to 63 in March. The score for March was lower than the near six-and-a-half year high recorded during January.
----------
Eurozone producer prices declined unexpectedly in February reflecting lower energy prices, official data revealed. Producer prices dropped 0.2% month-on-month after easing 0.3% in January, Eurostat reported. Prices were expected to remain flat in February. On a yearly basis, producer prices were down 1.7% versus a 1.4% drop in the prior month. The decline also exceeded consensus forecast of 1.6% fall.
----------
British Deputy Prime Minister Nick Clegg is preparing to take on Nigel Farage, the leader of the UK Independence Party, in a second televised debate on Britain's membership of the EU. The two men clashed in a first debate last week, with opinion polls afterwards suggesting that Clegg, leader of the pro-European Liberal Democrat party, had lost to the eurosceptic Farage. Conservative Prime Minister David Cameron and Ed Miliband, the leader of the opposition Labour party, have refused to take part in the debates, the first to see party leaders discuss the country's EU membership live on television.
----------
France's new prime minister, Manuel Valls, was meeting President Francois Hollande to discuss the formation of a new cabinet. The 51-year-old former interior minister replaced Jean-Marc Ayrault after voters punished his Socialist Party over the government's poor economic record by voting out scores of left-wing mayors. Valls, who is one of France's favourite politicians, is seen as a pragmatist.
----------
Politicians in Moscow criticized NATO for suspending all cooperation with Russia on civilian and military matters. The military alliance had lost all meaning with the end of the Cold War and was using the Ukraine crisis to pump fresh blood into its veins, said top foreign policy official Alexei Pushkov. This is an attempt to revive the alliance from its "half-dead" state, said Pushkov, the chairman of the Duma's Foreign Affairs Committee, according to the Interfax news agency.
----------
Top diplomats from the US and EU explored ways to vary their energy sources, amid an effort to cut Europe's dependency on Russia. The international community has been outraged by Russia's annexation of the Ukrainian peninsula of Crimea and the ensuing pressure it has been accused of applying on its neighbour. On Tuesday, the state-owned energy giant Gazprom announced that gas prices for Ukraine will rise by 30% because of 1.7 billion dollars in bills that have gone unpaid by Kiev. Russia has in the past been accused of using gas prices as a tool for political pressure.
----------
NATO is suspending all cooperation with Russia on civilian and military matters, the alliance's foreign ministers said Tuesday, raising also the possibility of deployments as part of their response to the Ukrainian crisis. "NATO's greatest responsibility is to protect and defend our territory and our people," Secretary General Anders Fogh Rasmussen said after the ministers' talks. "Russia's aggression against Ukraine is the gravest threat to European security in a generation."
----------
Fears faded of a destructive tsunami on the western seaboard of South America, after a magnitude-8.2 earthquake struck about 100 kilometres off northern Chile. The Chilean navy said a 2-metre wave had reached the northern coast about 45 minutes after the quake. The tsunami alert had been lifted across much of the country by 0500 GMT, Chilean daily La Tercera reported. Landslides cut roads and there were reports of infrastructure damage, after authorities in Santiago issued an evacuation order for the whole coastline.
----------
President Mahmoud Abbas said Tuesday he will press for Palestinian recognition at 15 United Nations bodies, a measure likely to jeopardize US efforts to save the faltering peace talks with Israel. The move comes after Palestinian outrage over Israel's refusal to release a fourth and final group of 26 Palestinian prisoners by a Saturday deadline.
----------
Copyright © 2014 Alliance News Limited. All Rights Reserved.


More News
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.